Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, while the prior Revision: v3.4.1 and a government funding/operating status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:55:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center staying open, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor wording and metadata updates were applied: the labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were adjusted in capitalization, and the revision/version was updated from v3.3.4 to v3.4.0; a 'Show glossary' control is now displayed.
    Difference
    0.2%
    Check dated 2026-01-28T06:15:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision metadata was updated: Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:10:41.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The Locations section was updated to add several new sites and regions and remove some existing location groupings; the revision is now v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:59:14.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the page footer, replacing the previous v3.3.1 revision; this is a cosmetic update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:08:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.